NCT03121300 is a clinical trial of CT Scan in Lung Cancer, sponsored by University of Michigan Rogel Cancer Center.

Who is sponsoring NCT03121300?

NCT03121300 is sponsored by University of Michigan Rogel Cancer Center.

What drugs are being tested in NCT03121300?

Interventions in NCT03121300: CT Scan, Lung CT, MRI, Walk Test, SGRQ, Biological Sample Collection, Toxicity, Cardiac Assessment.

What condition does NCT03121300 study?

NCT03121300 studies Lung Cancer.

Is NCT03121300 still recruiting?

NCT03121300 is currently completed. Last updated 17 October 2019.

Last reviewed 2019-10-17 · How we verify

NCT03121300

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional Imaging in Lung SBRT

Completed Last updated 17 October 2019

What this trial tests

trial testing CT Scan in Lung Cancer in 33 participants. Completed in 30 August 2019.

Timeline

6 February 2017

Primary endpoint
30 August 2019

30 August 2019

Quick facts

Lead sponsor	University of Michigan Rogel Cancer Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	33
Start date	6 February 2017
Primary completion	30 August 2019
Estimated completion	30 August 2019
Sites	1 location across United States

Drugs / interventions tested

CT Scan — full drug profile →
Lung CT
MRI — full drug profile →
Walk Test
SGRQ
Biological Sample Collection — full drug profile →
Toxicity
Cardiac Assessment

Conditions studied

Lung Cancer — all drugs for Lung Cancer →

Sponsor

University of Michigan Rogel Cancer Center

Who can join

18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Little is known about the safety of body radiation therapy (SBRT), especially the impact on pulmonary function, quality of life, and on functional changes within the lung itself. Radiation dose constraints and capturing functional changes on imaging are not well studied in this setting. The current study aims to evaluate the utility of advanced imaging to measure lung function prior to and after treatment and to assess the feasibility of using this data to adapt SBRT planning.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of CT Scan

Trials testing the same drug.

NCT06199479 — Radiologic Pathologic Correlation of Imaging to Distinguish True Progression From Pseudoprogression in Brain Malignancie · Phase 1 · recruiting
NCT04933617 — Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas · Phase 1 · terminated
NCT04946552 — Sympathetic Activation in Obesity · NA · completed
NCT04716907 — Thymic Function in Patients With COVID-19 · completed
NCT04518722 — CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids · terminated

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other University of Michigan Rogel Cancer Center trials

Trials by the same sponsor.

NCT06914479 — Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and · Phase 1 · recruiting
NCT07481344 — SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners · NA · not yet recruiting
NCT07526545 — Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · NA · not yet recruiting
NCT07443943 — A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive · Phase 2 · recruiting
NCT07365007 — A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Ca · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03121300 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan Rogel Cancer Center
Last refreshed: 17 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03121300.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing